These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 13450596)

  • 1. [Clinical and experimental results with BCM (beta-bis-1, 6-chloroethylamino-D-mannitol dihydrochloride)].
    SELLEI K; NEMETH L; ECKHARDT S; KELLNER B
    Magy Tud; 1957; 8(1-2):119-21. PubMed ID: 13450596
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical observations with 1, 6-bis(beta-chloroethylamino)-1, 6-deoxy-D-mannitol dihydrochloride (BCM) in malignant diseases.
    SELLEI C; ECKHARDT S
    Ann N Y Acad Sci; 1958 Apr; 68(3):1164-80. PubMed ID: 13627769
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experiences with BCM (degranol) beta-bis-chlorethylamino-D-mannitoldichlorhydrate].
    ECKHARDT A; SELLEI C; MOLNAR A; HARTAI F
    Krebsarzt; 1958 Feb; 13(2):73-5. PubMed ID: 13540175
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the inhibiting effect of a new nitrogen mustard derivative, 1, 6-bis(beta-chloraethylamino)-1, 6-desoxy-D-mannitol dihydrochloride (BCM), on tumor growth].
    KELLNER B; NEMETH L
    Orv Hetil; 1956 Sep; 97(36):981-4. PubMed ID: 13388307
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of fractionated doses of BCM [1,6-bix (beta-chloroethylamino)-1,6-desoxy-D-mannitol dihydrochloride] on guérin carcinoma of the rat].
    HOLCZINGER L; KELLNER B
    Z Krebsforsch; 1957; 62(1):90-4. PubMed ID: 13531427
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disappearance of symptoms of granuloma fungoides after mustard mannitol (BCM) therapy].
    BAKOS L; VENKEI T
    Orv Hetil; 1957 Apr; 98(17):442. PubMed ID: 13452498
    [No Abstract]   [Full Text] [Related]  

  • 7. [An experiment on increasing the effect of cytostatic drugs; increasing the active dosage of BCM through simultaneous use of a hibernation mixture].
    SELLEI C; HARTAI F; MOLNAR E; ECKHARDT S
    Medizinische; 1957 May; (19):722-3. PubMed ID: 13440433
    [No Abstract]   [Full Text] [Related]  

  • 8. [1, 6-Bis(beta-chlorethylamino)-1, 6-desoxy-D-mannit dichlorhydrate (BCM), a new nitrogen derivative].
    KELLNER B; NEMETH L
    Z Krebsforsch; 1956; 61(2):165-79. PubMed ID: 13353379
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathological and clinical effects of 1.6-bis(beta-chloraethylamino)-1.6-desoxy-D-mannite-dichlorhydrate/BCM.
    KELLNER B; NEMETH L; SELLEI C
    Acta Unio Int Contra Cancrum; 1957; 13(3):473-9. PubMed ID: 13469609
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental and clinical experiences with degranol].
    BENKO S
    Orv Hetil; 1958 Jul; 99(27):914-7. PubMed ID: 13566811
    [No Abstract]   [Full Text] [Related]  

  • 11. Experimental and clinical facts about degranol.
    BENKO S
    Ther Hung; 1958; 6(1):15-8. PubMed ID: 13625185
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical trials of a new nitrogen mustard, MX 101].
    IZARN P; POURQUIER H; GARY-BOBO J; PUJOL H; EMBERGER JM
    Montp Med; 1960 Nov; 58():178-83. PubMed ID: 13718407
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research on the antimitotic activity of a mannitol-nitrogen mustard complex (BCM) on meristem cells of Allium sativum L].
    DEYSSON G; TRUHAUT R
    C R Seances Soc Biol Fil; 1959; 153(2):215-8. PubMed ID: 13663405
    [No Abstract]   [Full Text] [Related]  

  • 14. [Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
    ZULIK R
    Arzneimittelforschung; 1958 Jun; 8(6):360-1. PubMed ID: 13546105
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trials of mechlorethamine-N-oxide in therapy of tumors].
    SELLEI C; ECKHARDT A
    Munch Med Wochenschr; 1958 May; 100(19):784-6. PubMed ID: 13565952
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pre- and post-operative dosage of degranol in operable cancer patients].
    RUBANYI P; SZEKELY J; NEMETH E
    Magy Seb; 1959 Mar; 12(1):65-8. PubMed ID: 13643065
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycosidation of 2,5-anhydro-3,4-di-O-benzyl-D-mannitol with different glucopyranosyl donors: a comparative study.
    Tegdes A; Medgyes G; Boros S; Kuszmann J
    Carbohydr Res; 2006 May; 341(6):776-81. PubMed ID: 16473342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic compounds. Part 21. Chloro-, methoxy-, and methoxycarbonyl-derivatives of (bis-2-chloroethylamino)-phenols and -anilines.
    Abela Medici AJ; Owen LN; Sflomos C
    J Chem Soc Perkin 1; 1977; (20):2258-63. PubMed ID: 563414
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of recent experiments with BCM.
    KELLNER B; NEMETH L; SELLEI C
    G Ital Chemioter; 1956; 3(3-4):352-4. PubMed ID: 13462182
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of poly-O-sulfated glycosides of 2,5-anhydro-D-mannitol.
    Kuszmann J; Medgyes G; Boros S
    Carbohydr Res; 2005 Jul; 340(10):1739-49. PubMed ID: 15953593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.